ADVANCE(CAT) gathers the efforts and expertise of 18 catalan institutions, both public and private, to speed up the conversion of advanced therapies from the idea to the product.
MISSION & VISION
Our mission: to consolidate and coordinate the scientific and technological resources to support all projects of cell therapy, gene therapy and tissue engineering and to accelerate the translation to the clinic and/or industrial exploitation.
Our vision: to become a well-known accelerator for research centers, hospitals and biotech companies for advanced therapies.
2016
Year Established
18
Number of Partners
63
Number of Scientists Involved
6
Ongoing R&D Projects
5
Ongoing Clinical Trials
2.8M€
Total Budget of the Project
MEMBERS
The consortium brings together the principal actors of Catalonia in the field of advanced therapies. ADVANCE(CAT) is not exclusive to its members but is open to collaborations with other entities of Catalonia and abroad, if you would like to know to benefit the potential of ADVANCE(CAT) please don’t hesitate to contact us.
PROJECTS
Clinical and industrial applications of cell therapy
ADVANCE(CAT) intends to promote the use of somatic stem cells towards clinical application and industrial exploitation. Further, ADVANCE(CAT) works on the potential of pluripotent stem cells, both PSCs and ESCs, for specific diseases
Clinical applications of tissue engineering
ADVANCE(CAT) intends to develop new artificial tissue production systems by combining both natural and artificial scaffolds with cells. ADVANCE(CAT) will develop 3D printing techniques of scaffolds in GMP environments.
Industrial Production
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed eiusmod tempor incidunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquid ex ea commodi consequat. Quis aute iure reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.